Last reviewed · How we verify
Ginkgo biloba standardized extract 24/6
Ginkgo biloba standardized extract 24/6 is a Herbal extract / Nootropic Small molecule drug developed by Milsing d.o.o.. It is currently FDA-approved for Age-related cognitive decline and memory impairment, Peripheral arterial occlusive disease, Tinnitus.
Ginkgo biloba extract improves blood flow and reduces oxidative stress through antioxidant and antiplatelet mechanisms.
Ginkgo biloba extract improves blood flow and reduces oxidative stress through antioxidant and antiplatelet mechanisms. Used for Age-related cognitive decline and memory impairment, Peripheral arterial occlusive disease, Tinnitus.
At a glance
| Generic name | Ginkgo biloba standardized extract 24/6 |
|---|---|
| Sponsor | Milsing d.o.o. |
| Drug class | Herbal extract / Nootropic |
| Modality | Small molecule |
| Therapeutic area | Neurology / Cognitive disorders |
| Phase | FDA-approved |
Mechanism of action
The 24/6 standardized extract (24% ginkgo flavone glycosides and 6% terpene lactones) enhances cerebral and peripheral microcirculation by inhibiting platelet-activating factor and scavenging free radicals. It also improves oxygen utilization and reduces blood viscosity, thereby supporting cognitive function and peripheral circulation.
Approved indications
- Age-related cognitive decline and memory impairment
- Peripheral arterial occlusive disease
- Tinnitus
- Vertigo and dizziness
Common side effects
- Headache
- Gastrointestinal upset
- Dizziness
- Bleeding risk (with anticoagulants)
Key clinical trials
- Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency (PHASE4)
- Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ginkgo biloba standardized extract 24/6 CI brief — competitive landscape report
- Ginkgo biloba standardized extract 24/6 updates RSS · CI watch RSS
- Milsing d.o.o. portfolio CI
Frequently asked questions about Ginkgo biloba standardized extract 24/6
What is Ginkgo biloba standardized extract 24/6?
How does Ginkgo biloba standardized extract 24/6 work?
What is Ginkgo biloba standardized extract 24/6 used for?
Who makes Ginkgo biloba standardized extract 24/6?
What drug class is Ginkgo biloba standardized extract 24/6 in?
What development phase is Ginkgo biloba standardized extract 24/6 in?
What are the side effects of Ginkgo biloba standardized extract 24/6?
Related
- Drug class: All Herbal extract / Nootropic drugs
- Manufacturer: Milsing d.o.o. — full pipeline
- Therapeutic area: All drugs in Neurology / Cognitive disorders
- Indication: Drugs for Age-related cognitive decline and memory impairment
- Indication: Drugs for Peripheral arterial occlusive disease
- Indication: Drugs for Tinnitus
- Compare: Ginkgo biloba standardized extract 24/6 vs similar drugs
- Pricing: Ginkgo biloba standardized extract 24/6 cost, discount & access